Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Jean-Raphaël Champagne Avocat/Associate Québec

Jean-Raphaël Champagne

Partner Fasken
The marijuana bill regulate several aspects of the market, including the types of products that can be sold and the scope of acceptable promotional initiatives.
Jurisdiction Quebec, 2013
Language(s) French, English
Office(s) Québec City


Jean-Raphaël Champagne advises clients on issues related to commercial, regulatory and competition law. He assists a wide variety of players in the technology and life sciences sectors. He has extensive experience drafting and reviewing contracts, with respect to regulatory compliance with Health Canada and the rules governing advertising and ethical standards applicable to the pharmaceutical industry. He also counsels clients on cannabis-related issues.

Jean-Raphaël advises clients on the complex regulatory framework applicable to the cannabis market.  Mr. Champagne is often asked by the press to comment on various aspects of cannabis law.

In large transactions, he also assists clients with strategic aspects and issues arising from competition law.

He has participated in many start-ups in several high-technology sectors. Jean-Raphaël has also participated in purchase and sale transactions involving private financings and technology transfers.  Before joining the Fasken team, he worked on the commercialization of university research products.

He is co-author of "The Pharma Legal Handbook – Canada".


Client Work

Date Client

Career & Education


  • MSc, Molecular biology and Law Université de Sherbrooke
  • PDDB, with major in Finance Vancouver Island University
  • LLB, Life Science Université de Sherbrooke


Fasken Institute



Article, Co-Author When is Software a Medical Device? Electronic Healthcare Law Review, LexisNexis, Volume 8, No. 4, May 2019, pages 44-45

Speaking Engagements


    Receive email updates from our team